After administering an inotropic medication to a patient in shock, the nurse monitors the patient for signs of:
Decreased cardiac output.
Increased afterload.
Increased cardiac output.
Slowing of the heart rate.
The Correct Answer is C
A. Decreased cardiac output: Inotropic medications are intended to improve cardiac function and increase cardiac output, so monitoring for signs of decreased cardiac output would be contrary to the expected therapeutic effect of these medications.
B. Increased afterload: Inotropic medications primarily affect the contractility of the heart muscle and do not typically have a direct effect on afterload (the force against which the heart must pump blood). While changes in afterload can occur as a secondary consequence of altered cardiac function, monitoring for signs of increased afterload would not be the primary focus after administering an inotropic medication.
C. Increased cardiac output.
Inotropic medications are drugs that affect the contractility of the heart muscle. They are often used in the management of shock to improve cardiac function and increase cardiac output. Therefore, after administering an inotropic medication, the nurse would monitor the patient for signs of increased cardiac output, such as improved peripheral perfusion, increased blood pressure, and resolution of signs and symptoms of shock.
D. Slowing of the heart rate: Inotropic medications can affect heart rate indirectly by altering cardiac output, but their primary effect is on contractility rather than heart rate. Monitoring for signs of bradycardia (slowing of the heart rate) may be appropriate in certain clinical situations, but it is not the primary consideration after administering an inotropic medication for shock.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is D
Explanation
A) Take albuterol first.
Taking albuterol before salmeterol does not address the potential interaction between the two medications. It is important to avoid taking them together rather than just adjusting the order of administration.
B) The order of administration does not matter.
The order of administration does matter when it comes to medications with potential interactions. In this case, both albuterol and salmeterol are bronchodilators, and taking them together can increase the risk of adverse effects.
C) Take salmeterol first.
Similar to taking albuterol first, taking salmeterol before albuterol does not address the potential interaction between the two medications. The priority is to avoid taking them together unless specifically directed by the healthcare provider.
D) They should not be taken together.
Albuterol and salmeterol are both bronchodilators used to treat respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). Albuterol is a short-acting beta agonist (SABA), typically used for quick relief of acute bronchoconstriction, while salmeterol is a long-acting beta agonist (LABA), used for long-term control and prevention of bronchospasm. Taking both medications together can increase the risk of side effects, including excessive stimulation of the beta receptors and potential cardiovascular effects. Therefore, it is important to follow healthcare provider's instructions and avoid taking albuterol and salmeterol together unless specifically directed to do so.
Correct Answer is ["B","D"]
Explanation
A. Diabetes: Diabetes is not typically a contraindication for decongestant use. However, patients with diabetes should be cautious with decongestants that contain sugar or other ingredients that may affect blood glucose levels.
B. Hypertension: Decongestants can cause vasoconstriction, which may lead to an increase in blood pressure. Patients with hypertension should use decongestants cautiously and under the guidance of a healthcare provider to avoid exacerbating their condition.
C. Hyperthyroidism: While decongestants can stimulate the sympathetic nervous system and may exacerbate symptoms of hyperthyroidism such as tachycardia and palpitations, hyperthyroidism is not typically considered a contraindication for decongestant use. However, patients with hyperthyroidism should use decongestants cautiously and consult with their healthcare provider.
D. Heart disease: Decongestants can increase heart rate and blood pressure, potentially exacerbating symptoms in patients with underlying heart conditions such as coronary artery disease, heart failure, or arrhythmias. Patients with heart disease should use decongestants cautiously and consult with their healthcare provider before use.
E. Allergic rhinitis: Allergic rhinitis is not typically a contraindication for decongestant use. In fact, decongestants are often used to relieve nasal congestion associated with allergic rhinitis. However, patients with allergic rhinitis should use decongestants cautiously and follow the recommended dosage instructions.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.